Impact Johnson and Johnson vaccine use pause will have on Lehigh Valley is unclear
Pennsylvania temporary halted the Johnson & Johnson vaccine Tuesday after the U.S. Centers for Disease Control and Prevention, and the Food and Drug Administration recommended a pause because of rare blood clots developed in six women between 18 and 48 years old. The news left Lehigh Valley health officials wondering what impact it could have on the state’s vaccine rollout that had recently been gathering steam.
Source: mcall.com